A Brucella ovis antigenic complex bearing poly-&unknown;-caprolactone microparticles confer protection against experimental brucellosis in mice

By Murillo M.   Grillo M.J.   Rene J.   Marn C.M.   Barberan M.   Goni M.M.   Blasco J.M.   Irache J.M.   Gamazo C.  

Vaccine, Vol. 19, Iss. 30, 2001-07 ,pp. : 4099-4106

Elsevier

Access to resources Recommend Favorite

Immunization of mice with recombinant L7/L12 ribosomal protein confers protection against Brucella abortus infection

By Oliveira S.C.   Splitter G.A.  

Vaccine, Vol. 14, Iss. 10, 1996-07 ,pp. : 959-962

Elsevier

Access to resources Recommend Favorite

Improvement of the Brucella abortus B19 vaccine by its preparation in a glycerol based medium

By Sangari F.J.   Aguero J.   Garcia-Lobo J.M.  

Vaccine, Vol. 14, Iss. 4, 1996-03 ,pp. : 274-276

Elsevier

Access to resources Recommend Favorite

The defect in the metabolism of erythritol of the Brucella abortus B19 vaccine strain is unrelated with its attenuated virulence in mice

By Sangari F.J.   Grillo M.J.   Jimenez De Bagues M.P.   Gonzalez-Carrero M.I.   Garcia-Lobo J.M.   Blasco J.M.   Aguero J.  

Vaccine, Vol. 16, Iss. 17, 1998-10 ,pp. : 1640-1645

Elsevier

Access to resources Recommend Favorite

Mucosal immunity in mice immunized with HIV-1 peptide conjugated to Brucella abortus

By Golding B.   Eller N.   Levy L.   Beining P.   Inman J.   Matthews N.   Scott D.E.   Golding H.  

Vaccine, Vol. 20, Iss. 9, 2002-01 ,pp. : 1445-1450

Elsevier

Access to resources Recommend Favorite